New Biotechnology
EFB’s official bimonthly journal, covering:
- Scientific research in genetic engineering, molecular biology, synthetic biology, genomics, and nanotechnology.
- Industrial and commercial applications, including healthcare, agriculture, biofuels, biocatalysis, bioremediation, and process engineering.
- Broader commentary on regulation, ethics, public perception, funding, education, and international collaboration.
New Biotechnology: A unified platform for research and the bioeconomy
In January 2025, Elsevier and the European Federation of Biotechnology (EFB) merged two of their leading journals—New Biotechnology and the EFB Bioeconomy Journal—into a single, comprehensive publication: New Biotechnology.
This unified journal bridges the gap between fundamental biotechnology research and its broader economic, societal, and policy contexts.
EFB Bioeconomy Journal
Focused on the interface of biology, economy, and society:
- Interdisciplinary research across natural sciences, technology, social sciences, and humanities.
- Socioeconomic and policy issues: Business models, ethics, governance, and finance in bioeconomic systems.
- Global perspective, with case studies from rural initiatives to industrial-scale processes.
